Antihypertensive drug class use and differential risk of urinary incontinence in community-dwelling older women

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67, Issue 12, 2012, Pages 1373-1378

  Peron, Emily P ^a   Zheng, Yan ^b   Perera, Subashan ^b   Newman, Anne B ^b,c   Resnick, Neil M ^b   Shorr, Ronald I ^d   Bauer, Douglas C ^e   Simonsick, Eleanor M ^f,g   Gray, Shelly L ^h   Hanlon, Joseph T ^b,c,i,j   Ruby, Christine M ^a,j  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NATIONAL INSTITUTE ON AGING   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; DOSE RESPONSE; FEMALE; HUMAN; RISK ASSESSMENT; STATISTICAL MODEL; URINE INCONTINENCE;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LOGISTIC MODELS; RISK ASSESSMENT; URINARY INCONTINENCE;

EID: 84869460783     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls177     Document Type: Article

References (38)

1. Fantl JA, Newman DK, Colling J, et al. Managing acute and chronic urinary incontinence. Clinical Practice Guideline. Quick Reference Guide for Clinicians, No. 2, 1996 Update. Washington, DC: Agency for Health Care Policy and Research; 1996. AHCPR Publication No. 96-0686. http://www.ncbi.nlm.nih.gov/ bookshelf/br.fcgi?book=hsarc hive&part=A32554#A32573. Accessed April 4, 2012.
2. McGrother C, Resnick M, Yalla SV, et al. Epidemiology and etiology of urinary incontinence in the elderly. World J Urol. 1998;16(suppl 1):S3-S9. (Pubitemid 128742903)
3. Ruby CM, Hanlon JT, Fillenbaum GG, Pieper CF, Branch LG, Bump RC. Medication use and control of urination among community-dwelling older adults. J Aging Health. 2005;17:661-674. (Pubitemid 41356219)
4. Pfsterer MH, Griffths DJ, Schaefer W, Resnick NM. The effect of age on lower urinary tract function: a study in women. J Am Geriatr Soc. 2006;54:405-412. (Pubitemid 43327151)
5. Tsakiris P, Oelke M, Michel MC. Drug-induced urinary incontinence. Drugs Aging. 2008;25:541-549. (Pubitemid 351918797)
6. DuBeau CE. Therapeutic/pharmacologic approaches to urinary incontinence in older adults. Clin Pharmacol Ther. 2009;85:98-102.
7. Resnick NM. Urinary incontinence in the elderly. Med Grand Rounds. 1984;3:281-290. (Pubitemid 15143262)
8. Ouslander JG. Management of overactive bladder. N Engl J Med. 2004;350:786-799. (Pubitemid 38209648)
9. Chang CH, Gonzalez CM, Lau DT, Sier HC. Urinary incontinence and self-reported health among the U.S. Medicare managed care benef-ciaries. J Aging Health. 2008;20:405-419. (Pubitemid 351601337)
10. Hawkins K, Pernarelli J, Ozminkowski RJ, et al. The prevalence of urinary incontinence and its burden on the quality of life among older adults with medicare supplement insurance. Qual Life Res. 2011;20:723-732.
11. Marshall HJ, Beevers DG. Alpha-adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibility. Br J Clin Pharmacol. 1996;42:507-509. (Pubitemid 26340154)
12. Finkelstein MM. Medical conditions, medications, and urinary incontinence. Analysis of a population-based survey. Can Fam Physician. 2002;48:96-101. (Pubitemid 34173189)
13. Ruby CM, Hanlon JT, Boudreau RM, et al. Health, Aging and Body Composition Study. The effect of medication use on urinary incontinence in community-dwelling elderly women. J Am Geriatr Soc. 2010;58:1715-1720.
14. Newman AB, Haggerty CL, Kritchevsky SB, Nevitt MC, Simonsick EM; Health ABC Collaborative Research Group. Walking performance and cardiovascular response: associations with age and mor-bidity-the Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci. 2003;58:715-720. (Pubitemid 36994946)
15. Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol. 1994;10:405-411. (Pubitemid 24339205)
16. Jackson RA, Vittinghoff E, Kanaya AM, et al. Health, Aging, and Body Composition Study. Urinary incontinence in elderly women: fndings from the Health, Aging, and Body Composition Study. Obstet Gynecol. 2004;104:301-307. (Pubitemid 40458876)
17. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc. 2003;289:2560-2572.
18. Semla TP, Ouslander JG. The American Geriatrics Society transitions to new leadership. J Am Geriatr Soc. 2010;58:820-821.
19. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J. 1986;293:1145-1151. (Pubitemid 16008923)
20. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J. 1992;304(6824):405- 412.
21. SHEP Cooperative Research Group. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension: fnal results of the Systolic Hypertension in the Elderly Program (SHEP). J Am Med Assoc. 1991;265(24):3255-3264.
22. Chazan BI, Duff DA, McCallum A, Whaley K. Comparative study of endralazine and hydralazine for the treatment of hypertension uncontrolled by a beta-blocker and diuretic. Curr Med Res Opin. 1986;10:150-158. (Pubitemid 16095802)
23. Horvath JS, Fletcher PJ, Bailey BP, Duggin GG, Hall B, Tiller D. Verapamil in essential hypertension: a comparison with atenolol plus hydralazine. Clin Exp Hypertens A. 1987;9:1185-1195. (Pubitemid 17127688)
24. Murray MD, Deer MM, Ferguson JA, et al. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med. 2001;111:513-520. (Pubitemid 33052348)
25. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353(9169):2001-2007.
26. Wan SH, Hart M, Hajjar I. A novel measurement index for antihy-pertensive medication burden and its use. Hypertension. 2009;54: e135-e136.
27. Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. J Am Med Assoc. 2005;293:935-948. (Pubitemid 40271125)
28. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-2724. (Pubitemid 37517412)
29. Hanlon JT, Boudreau RM, Roumani YF, et al. Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci. 2009;64:492-498.
30. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measures. 1977;1(3):385-401.
31. Teng EL, Chui HC. The Modifed Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314-318. (Pubitemid 17138128)
32. National Institutes of Health. Clinical guidelines on the identifcation, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res. 1998;6(suppl 2):S51-209.
33. Grodstein F, Lifford K, Resnick NM, Curhan GC. Postmenopausal hormone therapy and risk of developing urinary incontinence. Obstet Gynecol. 2004;103:254-260.
34. Hosmer DW Jr, Lemeshow S. Survival analysis: applications to ophthalmic research. Am J Ophthalmol. 2009;147:957-958.
35. Allison PD. Logistic Regression Using the SAS System: Theory and Application. Cary, NC: SAS Institute; 1999.
36. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc. 2000;283:1967-1975.
37. Asplund R. Nocturia, nocturnal polyuria, and sleep quality in the elderly. J Psychosom Res. 2004;56:517-525. (Pubitemid 38686691)
38. Sandvik H, Hunskaar S, Vanvik A, Bratt H, Seim A, Hermstad R. Diagnostic classifcation of female urinary incontinence: an epidemio-logical survey corrected for validity. J Clin Epidemiol. 1995;48:339-343.